Lilly France

Lilly, a healthcare company with an international dimension, has been established in France since 1962. Lilly France is present across the entire drug chain: from clinical research, through production, to marketing and export . At all stages of implementing our strategies and pursuing our objectives, Lilly France is guided by long-established essential values: respect for people, excellence and integrity. Three essential activities characterize Lilly France, in order to provide adapted and innovative therapeutic solutions to patients: • Innovate, with clinical research and various partnerships with public or private research institutions. • Produce, with the Fegersheim site, in Alsace, one of the largest production sites of the Eli Lilly and Company Group. • And help treat different diseases such as diabetes, cancer, autoimmune diseases in rheumatology and dermatology, pain syndromes, osteoporosis and psychiatric and neurological diseases. Lilly France, one ambition: to meet the challenges of the 21st century.